Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
Actual shortage: | 241 (8%) | |
Anticipated shortage: | 18 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-PRAZO TAB 1MG | 1MG | TABLET | Resolved | 2019-02-24 | 2019-04-08 | 76732 |
APO-PRAZO TAB 1MG | 1MG | TABLET | Resolved | 2020-04-13 | 2020-06-22 | 111946 |
APO-PRAZO TAB 1MG | 1MG | TABLET | Actual shortage | 2023-01-20 | 2024-03-27 | 181967 |
APO-PRAZO TAB 2MG | 2MG | TABLET | Resolved | 2017-11-28 | 2018-01-29 | 31019 |
APO-PRAZO TAB 2MG | 2MG | TABLET | Resolved | 2020-09-02 | 2020-10-16 | 123574 |
APO-PRAZO TAB 2MG | 2MG | TABLET | Actual shortage | 2023-04-06 | 2024-03-27 | 188943 |
APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2018-03-13 | 2018-06-12 | 42700 |
APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2018-11-21 | 2019-03-26 | 67409 |
APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2020-04-15 | 2020-06-22 | 112192 |
APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2020-08-12 | 2020-10-19 | 122074 |
APO-PRAZO TAB 5MG | 5MG | TABLET | Resolved | 2022-12-09 | 2023-01-20 | 177594 |
APO-PRAZO TAB 5MG | 5MG | TABLET | Actual shortage | 2023-03-02 | 2024-03-27 | 185924 |
APO-PREGABALIN | 150MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 447 |
APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 450 |
APO-PREGABALIN | 75MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 456 |
APO-PREGABALIN | 25MG | CAPSULE | Resolved | 2017-03-12 | 2017-10-10 | 728 |
APO-PREGABALIN | 75MG | CAPSULE | Resolved | 2017-04-24 | 2017-05-10 | 7704 |
APO-PREGABALIN | 300MG | CAPSULE | Resolved | 2017-05-24 | 2017-09-22 | 11041 |
APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2017-06-13 | 2018-01-19 | 12695 |
APO-PREGABALIN | 225MG | CAPSULE | Resolved | 2017-08-08 | 2017-09-22 | 18553 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |